NCT04595604

Brief Summary

Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks. ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery. Trimodal Prehabilitation Program is a recently introduced preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients. This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol. Additionally the effect of trimodal prehabilitation on gut microbiom diversity and its relation to clinical outcome will be analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 7, 2020

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 30, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2024

Completed
Last Updated

November 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

September 30, 2020

Last Update Submit

November 26, 2024

Conditions

Keywords

ERASprehabilitationfecal microbata

Outcome Measures

Primary Outcomes (10)

  • Length of hospital stay

    Postoperative length of hospital stay in days.

    45 days

  • Number of days spent on ICU (Intensive care unit).

    Number of days observed on ICU right after operation.

    45 days

  • Morbidity (early) classified after Clavien-Dindo.

    7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.

    7 days (until 8th postoperative day) postoperative

  • Morbidity (long term) classified after Clavien-Dindo.

    30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.

    30 days (until 31st postoperative day)

  • 30-day mortality

    30-day mortality of each patient will be recorded.

    30 days (until 31st postoperative day)

  • 90-day mortality

    90-day mortality of each patient will be recorded.

    90 days (until 91st postoperative day)

  • Change in preoperative functional status - 6MWD by operation

    6MWD (6-minute walking distance test)

    Measured points: 4 weeks before surgery, on day of hospital admission

  • Change in postoperative functional status - 6MWD by the end of rehabilitation

    6MWD (6-minute walking distance test)

    Measured points: 4 weeks before surgery, 8 weeks after operation

  • Change in preoperative functional status - FVC by operation

    Measured points: 4 weeks before surgery, on day of hospital admission

    Measured points: 4 weeks before surgery, on day of hospital admission

  • Change in preoperative functional status - FVC by the end of rehabilitation

    Measured points: 4 weeks before surgery, 8 weeks after operation

    Measured points: 4 weeks before surgery, 8 weeks after operation

Secondary Outcomes (1)

  • Change of alpha- and beta-diversity of fecal microbata

    Measured points: 4 weeks before surgery, on day of hospital admission and 8 weeks after surgery

Study Arms (2)

Trimodal prehabilitation + ERAS

EXPERIMENTAL

Patients receiving a formal preoperative preparation on: Physical status (walking, respiratory training) Nutrition (nutritional supplements) Mental status (weekly groups led by clinical psychologist on anxiety and depression management). Each patient will be treated in an ERAS program preoperatively.

Procedure: Trimodal rehabilitation + ERAS

ERAS + nutritional prehabilitation

ACTIVE COMPARATOR

Each patient will be treated in an ERAS program preoperatively. No specific preoperative training will be involved apart from nutritional status assessment and nutritional supplements.

Procedure: ERAS + nutritional prehabilitation

Interventions

Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.

Also known as: Prehabilitation
Trimodal prehabilitation + ERAS

Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.

Also known as: Enhanced Recovery After Surgery
ERAS + nutritional prehabilitation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient with histologically proven primary colorectal adenocarcinoma
  • any stage of colorectal cancer
  • elective operation
  • curative intention
  • informed consent signed by patient

You may not qualify if:

  • emergency operation
  • palliative operation
  • non-colorectal, second malignancy
  • pregnancy
  • patient not giving consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Surgery, St. Borbala Hospital

Tatabánya, 2800, Hungary

Location

St. Borbala Hospital

Tatabánya, 2800, Hungary

Location

Related Publications (2)

  • Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2023 May 10;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub3.

  • Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Preoperative ExerciseEnhanced Recovery After Surgery

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigators and assessors will be blinded regarding preoperative preparation. Both randomization process and rehabilitation process will be carried out by a trained nurse, physiotherapist and psychotherapist, neither of them will be involved in outcome assessment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients planned for elective, curative operations for colorectal cancer will be randomized into two groups: experimental group will take part in a dedicated 4-week multimodal preparation program followed by ERAS preoperative management, while control group will just participate in the ERAS program without specific physical and mental preparation. 2:1 randomization will be performed for interventional and control arm
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2020

First Posted

October 20, 2020

Study Start

September 7, 2020

Primary Completion

August 7, 2022

Study Completion

June 7, 2024

Last Updated

November 29, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, CSR
Time Frame
10 years

Locations